DiaMedica Therapeutics, Inc. (DMAC)
7.71
+0.12
(+1.58%)
USD |
NASDAQ |
Mar 06, 16:00
7.72
+0.01
(+0.13%)
After-Hours: 20:00
DiaMedica Therapeutics Cash from Investing (Quarterly) : -26.20M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| XOMA Royalty Corp. | 58.21M |
| Bristol Myers Squibb Co. | -1.458B |
| Avantor, Inc. | -39.70M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.617M |
| Cash from Financing (Quarterly) | 32.02M |
| Free Cash Flow | -27.71M |
| Free Cash Flow Per Share (Quarterly) | -0.1337 |
| Free Cash Flow to Equity (Quarterly) | -6.607M |
| Free Cash Flow to Firm (Quarterly) | -6.633M |
| Free Cash Flow Yield | -8.07% |